Late-stage traction alopecia where scarring has occurred responds poorly
Neuroligins and neurexins link synaptic function to cognitive disease
Wegovy is now uniquely positioned as the first and only GLP-1 treatment approved for MASH, complementing the already proven weight loss, cardiovascular benefits and extensive body of evidence linked to semaglutide, said Martin Holst Lange, executive vice president, chief scientific officer and head of Research and Development, at Novo Nordisk
When a medication is administered subcutaneously, it means that it is injected into this layer, allowing for slow and controlled absorption into the bloodstream
Research also shows it can improve insulin resistance, and may reduce the impact of uncontrolled diabetes and reduce respiratory symptoms